Genmab — Juni 2015
-
-
Tillykke med valget
http://finance.yahoo.com/q?s=^NBI -
Han kan nok ikke klare sig med at forære DF lidt ekstra grænsebomme.
-
GSK vil styrke kræftudviklingen
Britiske GlaxoSmithKline dæmper ikke på ambitionerne inden for kræftudvikling, selvom man i den seneste tid har været igennem mange nedskæringer.
(medwatch.dk)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind